Interleukin 4 (IL-4) is secreted by activated T cells and pleiotropically modulates both B-and T-lymphocyte function. In murine helper (CD4+) T-cell clones IL-4 production appears to be regulated independently of interferon Y and interleukin 2. To determine whether production of these lymphokines is also differentially regulated in uncloned human T cells, we studied lymphokine production *iy normal human peripheral T cells and T-cell subsets after ii vitro polyclonal activation. After maximal induction of lymphokine expression, IL-4 mRNA was detectable in <5% of CD41 and 1-2% of unfractionated T cells, whereas '33% and 60% of CD4' cells expressed detectable mRNA for interferon y and interleukin 2, respectively. This finding correlated with dramatically lower production of IL-4 mRNA and protein than of interferon rand interleukin 2 by peripheral blood and tonsillar T cells. The helper-inducer (CD4' CD45R-) T-cell subset, which significantly enhances in vitro immunoglobulin production, accounted for the preponderance of IL-4 mRNA accumulation and protein production by CD41 T cells; nevertheless, cells with detectable IL-4 mRNA constituted <10% of the CD4' CD45R-subset. Limitation of IL-4 production to a comparatively small population of normal human T cells could selectively regulate the effects of this lymphokine in T-cell-mediated immune responses; such selective regulation may be a fundamental mechanism for restricting the potentially pleiotropic effects of certain tymphokines to appropriate responder cells.Interleukin 4 (IL-4) is a T-cell lymphokine that modulates lymphocyte function by promoting B-cell growth, regulating immunoglobulin isotype expression, and promoting T-cell growth and cytotoxicity (1)(2)(3)(4). Interferon y (IFN-'y) (5,6) and, to a lesser extent, interleukin 2 (IL-2) (6, 7), which are primarily produced by activated T cells, also have pleiotropic effects on lymphoid cells. In certain cases all three lymphokines may have similar or synergistic activities, such as the enhancement of T-cell-mediated cytotoxicity (4,8), whereas in other situations, such as the regulation of immunoglobulin isotype expression by IL-4 and IFN-y, differential or antagonistic effects have been demonstrated (2, 9, 10).These in vitro findings raise the question as to how lymphokine production by activated T cells is regulated in vivo to result in an integrated effective immune response. One mechanism to facilitate distinct T-cell effector functions would be to limit the production of a lymphokine to a particular subtype ofT cells. Such segregation ofCD4' T-cell lymphokine production has been proposed by Mosmann and co-workers (11, 12) from the observation that most murine CD4' clones produce either IL-4 or IFN-y and IL-2 in a mutually exclusive fashion. However, most human CD4' T-cell clones do not appear to conform to this pattern (9, 13), and there is evidence that the patterns of lymphokine production obtained in clones may be influenced by the conditions used during the cloning process (14). In addition, c...